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Introduction
Cancer is the leading cause of  death in the world and is 
attributable to 13% of  total worldwide mortality, according 
to the World Health Organization (WHO).1,2 In Africa, the 5 
commonest cancers in males are Kaposi’s sarcoma (12.9% of  
all cancers in males) and cancer of  the liver (14.8%), prostate 
(9.5%), bladder (6.1%), and non-Hodgkin’s lymphoma 
(NHL) (5.7%). In females, cancer of  the cervix (23.3% of  
all cancers in females) and breast (19.2%), Kaposi’s sarcoma 
(5.1%), cancer of  the liver (5.0%), and NHL (3.7%) are the 
5 most common cancers.1–2 Environmental factors (such 
as tobacco use, alcohol, maize flour-based diet, as well as 
parasite and mold exposure), oncogenic viral infection 
(such as with hepatitis B, hepatitis C, human papillomavirus 
[HPV], or human immunodeficiency virus [HIV]) are known 
risk factors for development of  cancers.11 With the higher 
prevalence of  HIV and other infectious diseases in Africa 
compared to the developed world, the rate of  infection-
related cancers (thought to be 36% in Africa) is twice the 
world average.22 Mortality rates are drastically higher for 
cancer patients in the developing world for a multitude of  
reasons, including unavailable or disorganised screening 
modalities, delayed diagnosis, and limited treatment options.
In Malawi, cancer data are sparse but recent estimates 
from population-based cancer registries show that the age-
standardised incidence rates per 100,000 people for all types 
of  cancer have increased, especially AIDS-defining cancers.10 
In males, the incidence increased from 31 per 100,000 in 
1999–2002 to 56 per 100,000 people in 2007–2010, and 
in females it increased from 29 to 69 per 100,000 people.10 
Kaposi’s sarcoma, oesophageal cancer, and cervical cancer 
were the main causes for the increased incidence.
Malawi’s HIV prevalence is estimated to be 10.6% among 
adults 15 to 49 years of  age, and the country has seen an 
increase in antiretroviral therapy (ART) coverage from 4% 
in 2004 to 76% in June 2011.9 The high HIV incidence may 
partially explain Malawi’s high Kaposi’s sarcoma and cervical 
cancer rates.17 In contrast, HIV infection does not seem to 
confer increased risk of  breast, oesophageal, prostate, or 
many other common types of  cancer. To our knowledge, 
these factors have not been fully explored in our local setting.
Abstract
Background
Little is known about risk factors for different cancers in Malawi. This study aimed to assess risk factors for and epidemiologic patterns 
of  common cancers among patients treated at Kamuzu Central Hospital (KCH) in Lilongwe, and to determine the prevalence of  Human 
Immunodeficiency Virus (HIV) infection in the same population.
Methods
We analysed data from the hospital-based KCH cancer registry, from June 2009 to September 2012, including data from a nested 
substudy on coinfections among cancer patients. Demographics and behavioural variables, including smoking and alcohol use, were 
collected through personal interviews with patients. We assessed HIV prevalence across cancer types. The distribution of  cancer types 
was reported overall and by gender. Logistic regression was used to assess risk factors associated with common cancer types.
Results
Data from 504 registered cancer patients were included—300 (59.5%) were female and 204 (40.5%) were male. Mean age was 49 years 
(standard deviation, SD = 16). There were 343 HIV-negative patients (71.2%), and 139 (28.8%) were HIV-positive.  The commonest 
cancers were oesophageal (n = 172; 34.5%), cervical (n = 109; 21.9%), and Kaposi’s sarcoma (KS) (n = 52; 10.4%). Only 18% of  cancer 
cases were histologically confirmed. Patients with oesophageal cancer were likely to be older than 50 years (odds ratio, OR = 2.22), male 
(OR = 1.47), and smokers (OR = 2.02). Kaposi’s sarcoma patients had the highest odds (OR = 54.4) of  being HIV-positive and were 
also more likely to be male (OR = 6.02) and smokers. Cervical cancer patients were more likely to be HIV-positive (OR = 2.2) and less 
than 50 years of  age.
Conclusions
Age, smoking, and HIV are important risk factors for the 3 commonest cancer types (oesophageal, KS, and cervical) at this teaching 
hospital in Malawi. HIV is the single most important risk factor for Kaposi’s sarcoma and cervical cancer.
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Methods
Patients and procedures
This was a retrospective descriptive analysis of  data 
collected on patients enrolled into Cancer and Comorbid 
Infections (CANCO) study at Kamuzu Central Hospital 
(KCH), in Lilongwe, Malawi, from June 2009 to September 
2012. KCH is a 1250-bed referral hospital, which serves 
about 5 million people annually. It serves as cancer referral 
hospital for the Northern and Central regions of  Malawi, 
whose total population is roughly 9 million. The CANCO 
study was nested within the KCH cancer registry, which 
sought to assess comorbid infections in cancer patients. 
Inclusion criteria for CANCO were: adult patients 18 years 
of  age or older, presenting to a KCH ward or clinic with 
a clinically suspected or histologically confirmed diagnosis 
of  cancer at any site, and having not had received treatment 
(chemotherapy, surgery, or radiotherapy) more than 4 weeks 
prior to enrolment. Cancer cases were identified by data 
clerks through daily review of  departmental registers, as 
well as weekly attendance at specialty clinics. Demographic 
and behavioural variables, such as smoking and alcohol use, 
were collected through personal interviews with patients by 
study physicians and nurses, using a structured questionnaire 
administered to eligible participants. Self-reported tobacco 
and alcohol use was not quantified. Clinical assessments 
of  participants included tumour measurements in the 3 
longest dimensions, using a tape measure. Tumours not 
obviously identifiable on physical exam were evaluated using 
an imaging device (ultrasound and x-ray, or occasionally 
computed tomography [CT] scan, or magnetic resonance 
imaging [MRI]).
Performance status, using the Karnofsky Performance 
Scale, was determined. Diagnostic testing for HIV, CD4 
count, hepatitis B, schistosomiasis ova in urine and stool, 
and malaria (thick film) were carried out where resources 
permitted. This analysis does not include all the variables in 
the database.
Data management and analysis
Data were entered into the KCH Malawi cancer registry 
database, as well as the AIDS Malignancy Clinical Trials 
Consortium surveys for AIDS-related malignancies 
(lymphoma, cervical cancer, and Kaposi’s sarcoma). The 
data were extracted from the database into Microsoft Excel. 
Baseline characteristics were summarised using frequencies 
with percentages or means with standard deviations (SDs). 
We compared differences in distribution between each risk 
factor variable, according to cancer site and stage, using 
Fisher’s exact test. We estimated the odds of  being HIV-
positive with a particular cancer diagnosis using a logistic 
regression model to assess risk factors for common types 
of  cancer. We considered a P-value of  0.05 or less to be 
significant. All analyses were performed using Stata SE 
version 12.1 (StataCorp, College Station, TX, USA)
Ethical approval
The CANCO study was approved by the National Health 
Science Research Committee (NHSRC) in 2009 (Approval 
number NHSRC #732).
Results
Overall, 1453 cancer cases were recorded into the KCH 
cancer registry between June 2009 and September 2012. 
The participants were referred from 6 hospital departments, 
namely Medicine, Surgery, Obstetrics and Gynaecology, 
Ophthalmology, and Dentistry. Data from 504 registered 
cancer patients, who were enrolled into the CANCO study, 
were included, 300 (59.5%) of  whom were female and 204 
of  whom (40.5%) were male. The mean age was 49 years 
(SD = 16). The mean age for males was 50 years (SD = 
16), and the mean age for females was 49 years (SD = 15). 
There were 139 (28.8%) HIV-positive patients included in 
the analysis, for whom CD4 count and viral load were not 
routinely tested.
The 4 most common cancers were oesophageal (n = 172; 
34.5%), cervical (n = 109; 21.9%), Kaposi’s sarcoma (n = 
52; 10.4%), and breast cancer (n = 37; 7.4%). Other cancers 
included in the registry were: head and neck cancers (n = 22; 
4.4%), bladder cancer (n = 20; 4.0%), other genitourinary 
cancers (n = 16; 3.2%), lymphoma (n = 13; 2.6%), 
gastrointestinal cancers (n = 10, 2.0%), eye cancer (n = 8; 
1.6%), other gynaecologic cancers (n = 6; 1.2%), sarcoma (n 
= 6; 1.2%), other skin cancers (n = 5;  1.0%), and leukaemias 
(n = 5; 1.0%) (Table 1).
Patients with oesophageal cancer were likely to be older than 
50 years (odds ratio, OR = 2.22), male (OR = 1.47), and 
tobacco smokers (OR = 2.02). Kaposi’s sarcoma patients 
were more likely to be HIV-positive (OR = 54.4) and male 
(OR = 6.02). Cervical cancer patients were more likely to be 
HIV-positive (OR = 2.2).
Working diagnoses were documented for 498 of  the 
504 cases. Owing to the limited scale and availability of  
pathology services during the patient enrolment period, 
only 90 (18%) of  the cases had histologically confirmed 
cancer diagnoses. Other diagnoses were made by clinical 
assessment. Most (96%) of  the Kaposi’s sarcoma cases 
were clinically diagnosed, except for the 4% of  endemic 
Kaposi’s sarcoma cases that were confirmed histologically. 
For cervical, breast, head and neck, and oesophageal cancers, 
clinical diagnoses were made in 91%, 81%, 82%, and 68% 
of  cases, respectively. The highest proportion of  histological 
diagnoses was among oesophageal cancers (32%).
Table 1: Cancer types diagnosed among patients at Kamuzu Central 
Hospital, Lilongwe, between June 2009 and September 2012
Total Male Female
Type of cancer n (%) n (%) n (%)
Oesophageal 172 (34.5) 92 (45.8) 80 (26.9)
Cervical 109 (21.9) 0 (0.0) 109 (36.7)
Kaposi Sarcoma 52 (10.4) 40 (19.9) 12 (4.0)
Breast 37 (7.4) 0 (0.0) 37 (12.5)
Head and neck 22 (4.4) 12 (6.0) 10 (3.4)
Bladder 20 (4.0) 10 (5.0) 10 (3.4)
Other genitourinary 16 (3.2) 14 (7.0) 2 (0.7)
Lymphoma 13 (2.6) 7 (3.5) 6 (2.0)
Gastrointestinal 10 (2.0) 4 (2.0) 6 (2.0)
Eye 8 (1.6) 2 (1.0) 6 (2.0)
Other gyanaecologic 6 (1.2) 0 (0.0) 6 (2.0)
Sarcoma 6 (1.2) 3 (1.5) 3 (1.5)
Other skin 5 (1.0) 4 (2.0) 1 (0.3)
Leukaemia 5 (1.0) 4 (2.0) 1 (0.3)
Others 17 (3.4) 9 (4.5) 8 (2.7)
Missing 6 3 3
Total 504 204 300
Table 1: Cancer types diagnosed among patients at Kamuzu 
Central Hospital, Lilon we, between June 2009 and September 
2012
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in the analysis. Ninety percent of  Kaposi’s sarcoma patients 
were HIV-positive, as were 27% of  cervical cancer patients 
and 46% of  lymphoma patients. Among HIV-positive 
individuals included in the study, 54% reported being on 
antiretroviral therapy (ART) and 24% were not on ART. 
ART status was undocumented for 22% of  HIV-positive 
patients. Among HIV-positive patients with cervical cancer, 
Kaposi’s sarcoma, and lymphoma, 60%, 45%, and 67% were 
on ART, respectively.
Discussion
The 4 commonest cancers among patients at KCH during 
the study period were cancer of  the oesophagus, Kaposi’s 
sarcoma, cervical cancer, and breast cancer—together 
contributing to more than 70% of  all cancer cases in the 
study population. Cancer of  the oesophagus alone comprised 
over one-third of  the cases, followed by cervical cancer 
contributing to over one-fifth (21%) and then Kaposi’s 
sarcoma and breast cancer. Among the females, cervical 
cancer was the commonest cancer contributing to more 
than one third (36.7%) of  all cancers in females, followed by 
cancer of  oesophagus, breast cancer, and Kaposi Sarcoma. 
Among males, oesophageal cancer was most common, 
accounting for 45% of  cancer diagnoses in men.
The findings of  this clinic-based study are similar to those 
of  a recent analysis of  data from a nationwide population-
based Malawian cancer registry,10 with oesophageal cancer, 
Kaposi’s sarcoma, and cervical cancer being among the 
most common cancers in both analyses. In contrast to our 
findings, however, Kaposi’s sarcoma (and not oesophageal 
cancer) was found to be the commonest diagnosis in the 
nationwide registry. This difference may be partly explained 
by the differences in study populations. Additionally, an 
Among patients with the 4 most common cancers 
(oesophageal, cervical, Kaposi’s sarcoma, and breast), 64% 
were younger than 55 years of  age, 26 % were either past 
or current smokers, and 24% were alcohol drinkers of  any 
amount and any duration. The ages of  oesophageal cancer 
patients ranged from 23 to 83 years, and 52% of  them were 
older than 55 years. The majority of  the Kaposi’s sarcoma 
patients (79%) were under the age of  45. Seventy-two percent 
of  cervical cancer patients and 76% of  breast cancer patients 
were less than 55 years old.
Tobacco use was most common among oesophageal cancer 
and Kaposi’s sarcoma patients, of  whom 39% and 37% were 
smokers, respectively. For alcohol use, the highest prevalence 
(46%) was observed among patients with Kaposi’s sarcoma, 
while 33% of  oesophageal cancer patients were alcohol 
consumers. Most of  the breast cancer (94%) and cervical 
cancer (95%) patients had no history of  smoking or alcohol 
consumption (Table 3).
HIV status was documented in 482 (96%) of  the 504 cases 
included in the analysis; 139 patients (28%) were documented 
as HIV-positive. Although oesophageal cancer was the most 
common cancer among those included in the analysis, patients 
with Kaposi’s sarcoma were 54.4 times were more likely to 
be HIV-positive than those with cancer of  oesophagus (P ≤ 
0.001). Of  the cancer diagnoses among patients with HIV, 
32% were Kaposi’s sarcoma and 28% were cervical cancer. 
Patients with cervical cancer were 2.21 times more likely to 
be HIV-positive than those with cancer of  oesophagus (P = 
0.009). Patients with breast cancer were 1.73 times more likely 
to be HIV-positive than those with oesophageal cancer (P = 
0.231). HIV-associated cancers (Kaposi’s sarcoma, cervical 
cancer, and NHL) constituted 36% of  all cancer diagnoses 
Table 2: Common cancer types by age group among patients at Kamuzu Central Hospital, Lilongwe, 
between June 2009 and September 2012
Age group 
(years)
Oesophagus Kaposi’s sarcoma Cervix Breast P-value
n (%) n (%) n (%) n (%) (Fisher's exact)
< 25 6 (3.5) 3 (5.8) 4 (3.7) 2 (5.4)
0.004
25 to 34 10 (5.8) 23 (44.2) 13 (11.9) 5 (13.8)
35 to 44 28 (16.3) 15 (28.9) 34 (31.2) 11 (29.7)
45 to 54 39 (22.7) 6 (11.5) 28 (25.7) 10 (27.0)
≥ 55 89 (51.7) 5 (9.6) 30 (27.5) 9 (24.3)
Total 172 52 109 37
Co    ag  gro a pati at Ka l, e, 
 June 2 09 and September 2012
Table 3: Smoking and alcohol consumption history by cancer type among 
patients at Kamuzu Central Hospital, Lilongwe, between June 2009 and 
September 2012
Variable
Oesophagus 
n (%)
Kaposi's sarcoma 
n (%)
Cervix 
n (%)
Breast 
n (%)
Tobacco use
Never 101 (60.8) 33 (63.5) 102 (93.6) 35 (94.6)
Past and current 65 (39.2) 19 (36.5) 7 (6.4) 2 (5.4)
Alcohol use
Never 111 (66.9) 28 (53.8) 103 (94.5) 35 (94.6)
Past and current 55 (33.1) 24 (46.2) 6 (5.5) 2 (5.4)
Total 166 52 109 37
Table 3: Smoking and alcohol consumption history by cancer type among patients at Kamuzu 
Central Hospital, Lilongwe, between June 2009 and September 2012
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cancer cases by clinical misdiagnosis (among both HIV-
positive and HIV-negative individuals). Our observation that 
cervical cancer was the commonest cancer among young 
nonsmoking females is consistent with findings by others in 
South Africa and Malawi.10
We observed that Kaposi’s sarcoma was 3 times more 
common in the males than females and commoner in the 
younger individuals (less than 45 years of  age), with half  of  
the cases occurring in people less than 35 years of  age. These 
findings regarding gender and age patterns are consistent 
with other studies.28,29 The high Kaposi’s sarcoma prevalence 
can be explained by the high HIV prevalence in this age 
group. We also observed that Kaposi’s sarcoma was the 
commonest HIV-associated cancer in our study population. 
This is in agreement with findings from elsewhere that report 
that HIV infection increases the risk of  Kaposi’s sarcoma 
by 50- to 100-fold.28 Three case–control studies from Africa 
showed increased Kaposi’s sarcoma risk of  30- to 50-fold 
in association with HIV, rising to 1600-fold in HIV-positive 
individuals with high HHV8 antibody titres.4,13 ART for 
treating HIV in adults has been reported to cause a decline 
in the incidence of  Kaposi’s sarcoma in Western countries.43 
In Malawi, data are needed to establish if  this is true in our 
setting.
In this study, we have not determined whether the incidence 
of  AIDS-defining cancers have decreased since the beginning 
of  the ART scale-up, in 2005. The first reason for this is that 
we did not have prevalence data until 2012, and the second 
reason is that determination of  incidence rates requires 
longitudinal studies or the use of  population-based cancer 
registries, both of  which require more time and resources 
than are normally available in our setting. The careful 
characterisation of  incidence trends of  HIV-associated 
malignancies would require the availability of  comprehensive 
population-based cancer registry data, including careful 
determination and documentation of  HIV status.
The main strength of  this study lies in its comprehensive 
dataset, which is more extensive than what can usually 
be obtained from routine clinical data in our setting. 
The demographic characterisation of  participants was 
comprehensive. However, diagnostic errors resulting from 
oesophageal cancer study, which enrolled patients within 
the time period captured by our study, may have  introduced 
a sampling bias in favour of  including more oesophageal 
cancer patients in the KCH cancer registry during the period 
under investigation.
The high prevalence of  oesophageal cancer in males may 
be attributable to the higher prevalence of  smoking (39%) 
in our population, compared to 25.9% overall in Malawi.26 
Tobacco and alcohol consumption, known risk factors for 
the development of  oesophageal cancer in many countries, 
have also been documented as important factors in Africa 
in studies conducted from the 1980s onward. The effect of  
increased alcohol and tobacco consumption on oesophageal 
cancer incidence in Africa has not been delineated. It is 
unclear why, for example, lung cancer (which has a well 
established association with smoking) was not commonly 
observed in our study population. It is also unclear why 
(with a mean age of  55 years among affected individuals) 
oesophageal cancer affects younger people in our study 
population than, for example, the United States, where the 
mean age at diagnosis of  oesophageal cancer is 67 years.
HIV infection did not seem to be associated with cancer of  
the oesophagus in our study population. This is consistent 
with previous findings in other cohorts.3,10,12,13
Cancer of  the cervix was classified as an AIDS-defining 
cancer by the U.S. Centers for Disease Control and Prevention 
as early as 1993.43 HIV has been found to be associated with 
cervical cancer in case–control and cohort studies in South 
Africa and Uganda, with odds ratios between 1.6 and 2.4.40 
It is now recognised that most cervical cancer is caused by 
HPV. In our study, the odds of  HIV infection among cervical 
cancer patients were not much different from the odds of  
HIV infection among breast cancer patients (OR of  2.2 vs 
1.7), and were much lower than the odds among Kaposi’s 
sarcoma patients (OR = 54). These associations differ from 
those found by other researchers.4 The lower OR for cervical 
cancer (as compared to Kaposi’s sarcoma) may suggest that 
increased incidence resulting from HIV infection may be less 
pronounced for cervical cancer than Kaposi’s sarcoma. In 
this study, it may also be explained by the lack of  histological 
diagnoses, which may have led to overestimation of  cervical 
Figure 1: HIV status among patients diagnosed with common cancer types at Kamuzu Central 
Hospital between June 2009 and September 2012
Type of cancer
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the lack of  pathological diagnostic capacity, may have led 
to errors in prevalence estimates, especially for cancers with 
wide differential diagnoses.
Conclusions
This study systematically described cancer burden, 
distribution, and risk factors at a central teaching hospital in 
Malawi. It has demonstrated that age, smoking, and HIV are 
important risk factors for some of  the most common cancer 
types. Further research is required to confirm associations 
and to assess trends in cancer burden, as well as to evaluate 
the impact of  ART on the incidences of  all AIDS-defining 
cancers in Malawi.
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